Characterization of EpCAM in thyroid cancer biology by three-dimensional spheroids in vitro model
暂无分享,去创建一个
[1] Yurong Lu,et al. Vemurafenib activates the sonic hedgehog pathway and promotes thyroid cancer stem cell self-renewal. , 2023, Endocrine-related cancer.
[2] O. Merkel,et al. An In Vitro Approach to Model EMT in Breast Cancer , 2023, International journal of molecular sciences.
[3] L. Persani,et al. FAM83B is involved in thyroid cancer cell differentiation and migration , 2022, Scientific Reports.
[4] M. Ringel,et al. Thyroid cancer, recent advances in diagnosis and therapy , 2021, International journal of cancer.
[5] M. Tomlinson,et al. The metalloproteinase ADAM10 requires its activity to sustain surface expression , 2020, Cellular and Molecular Life Sciences.
[6] Raymond B. Runyan,et al. Guidelines and definitions for research on epithelial–mesenchymal transition , 2020, Nature Reviews Molecular Cell Biology.
[7] E. Grassi,et al. Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma , 2020, Oncogene.
[8] M. Hedayati,et al. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review , 2019, Endocrine.
[9] F. Azuaje,et al. Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment , 2019, Nature Communications.
[10] O. Gires,et al. Membrane-associated epithelial cell adhesion molecule is slowly cleaved by γ-secretase prior to efficient proteasomal degradation of its intracellular domain , 2018, The Journal of Biological Chemistry.
[11] A. Pietras,et al. The p75 neurotrophin receptor enhances HIF‐dependent signaling in glioma , 2018, Experimental cell research.
[12] B. Lenarčič,et al. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers , 2018, PLoS biology.
[13] Joseph Szymborski,et al. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer , 2018, Oncogene.
[14] D. Lindgren,et al. CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells. , 2017, Cell reports.
[15] H. Saya,et al. The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer , 2017, Oncotarget.
[16] C. Compton,et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.
[17] N. McGranahan,et al. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.
[18] V. Vaira,et al. Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors , 2016, Oncotarget.
[19] G. Semenza,et al. Hypoxia-Inducible Factors: Master Regulators of Cancer Progression. , 2016, Trends in cancer.
[20] Jianhua Ruan,et al. EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition. , 2016, Cancer research.
[21] C. Barrias,et al. A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion , 2016, Scientific Reports.
[22] G. Semenza. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors. , 2015, Clinical science.
[23] G. Vitale,et al. SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways , 2015, Oncotarget.
[24] M. Charbonneau,et al. High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells* , 2015, The Journal of Biological Chemistry.
[25] L. weiswald,et al. Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.
[26] T. Kirkegaard,et al. The broad-spectrum metalloproteinase inhibitor BB-94 inhibits growth, HER3 and Erk activation in fulvestrant-resistant breast cancer cell lines. , 2014, International journal of oncology.
[27] T. Okada,et al. Coexpression of EpCAM, CD44 Variant Isoforms and Claudin-7 in Anaplastic Thyroid Carcinoma , 2014, PloS one.
[28] G. Mazzoleni,et al. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer , 2014, Histopathology.
[29] J. Huse,et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.
[30] S. Yamashita,et al. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines. , 2014, Endocrine journal.
[31] G. Clayman,et al. Detection of thyroid cancer stem cells in papillary thyroid carcinoma. , 2014, The Journal of clinical endocrinology and metabolism.
[32] Jian-kui Han,et al. Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review) , 2014, Oncology reports.
[33] B. Giepmans,et al. EpCAM: structure and function in health and disease. , 2013, Biochimica et biophysica acta.
[34] D. Cui,et al. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. , 2013, International journal of oncology.
[35] R. Oehler,et al. Vimentin cleavage in end-stage renal disease is not related to apoptosis , 2013 .
[36] Min Li,et al. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway , 2013, Molecular and Cellular Biochemistry.
[37] B. Giepmans,et al. EpCAM proteolysis: new fragments with distinct functions? , 2013, Bioscience reports.
[38] B. Mack,et al. EpCAM regulates cell cycle progression via control of cyclin D1 expression , 2013, Oncogene.
[39] F. Papaccio,et al. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] H. Hamada,et al. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins. , 2012, Developmental biology.
[41] Wenxiu Zhao,et al. Embryonic Stem Cell Markers , 2012, Molecules.
[42] S. Chiou,et al. Targeting Signal Transducer and Activator of Transcription 3 Pathway by Cucurbitacin I Diminishes Self-Renewing and Radiochemoresistant Abilities in Thyroid Cancer-Derived CD133+ Cells , 2012, Journal of Pharmacology and Experimental Therapeutics.
[43] Arun K. Ghosh,et al. Developing β‐secretase inhibitors for treatment of Alzheimer’s disease , 2012, Journal of neurochemistry.
[44] K. Akassoglou,et al. Oxygen-dependent cleavage of the p75 neurotrophin receptor triggers stabilization of HIF-1α. , 2011, Molecular cell.
[45] Hsiang-Po Huang,et al. Epithelial Cell Adhesion Molecule (EpCAM) Complex Proteins Promote Transcription Factor-mediated Pluripotency Reprogramming* , 2011, The Journal of Biological Chemistry.
[46] Reigh-Yi Lin. Thyroid cancer stem cells , 2011, Nature Reviews Endocrinology.
[47] L. Vermeulen,et al. Cancer stem cell niche: the place to be. , 2011, Cancer research.
[48] S. S. Chauhan,et al. Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers , 2010, PloS one.
[49] R. Ralhan,et al. EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis , 2010, BMC Cancer.
[50] G. Smyth,et al. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.
[51] E. Neilson,et al. Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.
[52] T. Wang,et al. Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 , 2009, Stem cells.
[53] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[54] Takashi Sakurai,et al. Crystal Structure of an Active Form of BACE1, an Enzyme Responsible for Amyloid β Protein Production , 2008, Molecular and Cellular Biology.
[55] D. Deforce,et al. Differential proteome analysis of normal and osteoarthritic chondrocytes reveals distortion of vimentin network in osteoarthritis. , 2008, Osteoarthritis and cartilage.
[56] H. Scholz,et al. Hypoxia-inducible Factor-1 (HIF-1) Is a Transcriptional Activator of the TrkB Neurotrophin Receptor Gene* , 2007, Journal of Biological Chemistry.
[57] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[58] G. Sauter,et al. High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer , 2004, Breast Cancer Research and Treatment.
[59] G. Schäfer,et al. Overexpression of Epithelial Cell Adhesion Molecule Antigen in Gallbladder Carcinoma Is an Independent Marker for Poor Survival , 2004, Clinical Cancer Research.
[60] C. Holding,et al. Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.
[61] H. A. Bakker,et al. The structural analysis of adhesions mediated by Ep-CAM. , 1999, Experimental cell research.
[62] H. A. Bakker,et al. Cytoplasmic Tail Regulates the Intercellular Adhesion Function of the Epithelial Cell Adhesion Molecule , 1998, Molecular and Cellular Biology.
[63] H. A. Bakker,et al. Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell–Cell Interactions Mediated by Classic Cadherins , 1997, The Journal of cell biology.
[64] H. A. Bakker,et al. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule , 1994, The Journal of cell biology.
[65] S. Weiss,et al. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.
[66] M. Herlyn,et al. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[67] I. Căruntu,et al. EpCAM (MOC-31) - immunohistochemical profile and clinico-pathological correlations in different histological variants of papillary thyroid carcinoma. , 2019, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[68] M. Charbonneau,et al. Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells. , 2007, The Journal of biological chemistry.